Endogenous Regulators of Adult CNS Neurogenesis
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1829-1840
Author(s):
Theo Hagg
JNK Signalling: A Possible Target to Prevent Neurodegeneration
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1875-1886
Author(s):
Tiziana Borsello and Gianluigi Forloni
The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
Journal:
Current Neuropharmacology
Volume:
5
Page:
73-80
Author(s):
John C. Ashton and Michelle Glass
Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
Journal:
Current Neuropharmacology
Volume:
5
Page:
81-97
Author(s):
Balapal S. Basavarajappa
Parkinsons Disease: Genetics and Beyond
Journal:
Current Neuropharmacology
Volume:
5
Page:
99-113
Author(s):
N. N. Inamdar, D. K. Arulmozhi, A. Tandon and S. L. Bodhankar
Current Experimental Therapy for Alzheimers Disease
Journal:
Current Neuropharmacology
Volume:
5
Page:
127-134
Author(s):
Sheng Chen, Xiao-Jie Zhang, Liang Li and Wei-Dong Le
The Application of Single Nucleotide Polymorphism Microarrays in Cancer Research
Journal:
Current Genomics
Volume:
8
Page:
219-228
Author(s):
Xueying Mao, Bryan D. Young and Yong-Jie Lu
Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes
Journal:
Current Genomics
Volume:
8
Page:
234-251
Author(s):
S.A. Deepak, K.R. Kottapalli, R. Rakwal, G. Oros, K.S. Rangappa, H. Iwahashi, Y. Masuo and G.K. Agrawal
Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
119-134
Author(s):
Alfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, Monia Rocco, Giuseppe Manzo and Michele Caraglia
Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
175-186
Author(s):
Constantinos Mikelis, Marina Koutsioumpa and Evangelia Papadimitriou